<SEC-DOCUMENT>9999999995-26-001409-index.html : 20260501
<SEC-HEADER>9999999995-26-001409.hdr.sgml : 20260501
<ACCEPTANCE-DATETIME>20260501001523
ACCESSION NUMBER:		9999999995-26-001409
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260430
DATE AS OF CHANGE:		20260501
EFFECTIVENESS DATE:		20260430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hemab Therapeutics Holdings, Inc.
		CENTRAL INDEX KEY:			0002114044
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				414241952
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-294989
		FILM NUMBER:		26928620

	BUSINESS ADDRESS:	
		STREET 1:		101 MAIN STREET
		STREET 2:		SUITE 1220
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		45 2138 7627

	MAIL ADDRESS:	
		STREET 1:		101 MAIN STREET
		STREET 2:		SUITE 1220
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>